A detailed history of Numerai Gp LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Numerai Gp LLC holds 14,640 shares of ZTS stock, worth $2.49 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
14,640
Previous 7,513 94.86%
Holding current value
$2.49 Million
Previous $1.22 Billion 96.92%
% of portfolio
0.45%
Previous 0.34%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$156.48 - $175.67 $1.12 Million - $1.25 Million
7,127 Added 94.86%
14,640 $2.41 Billion
Q4 2024

Feb 14, 2025

BUY
$162.24 - $194.42 $1.22 Million - $1.46 Million
7,513 New
7,513 $1.22 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $79.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Numerai Gp LLC Portfolio

Follow Numerai Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Numerai Gp LLC with notifications on news.